PatientSafe Solutions, a US-based hospital safety company backed by local drugs group Merck’s corporate venturing unit, has raised $20m in its series C round.

Last month, PatientSafe said it had raised $13m, according to an updated filing with the Securities and Exchange Commission.

Merck’s Global Health Innovation (GHI) fund led the C round and was joined by existing venture investors, including Camden Partners, TPG Capital, and Psilos Group.

Maxwell Kahn, an investment principal at Merck GHI, has joined PatientSafe’s board and said: “PatientSafe Solutions has the potential to deliver value for hospitals and health systems, with a focus on improving patient outcomes and lowering costs.”

His other board seat is Healthsense, which Merck backed in September as part of a $7m round and has just replaced its chief executive, Brian Bischoff, with AR Weiler.

The closing of the C round, followed PatientSafe, which was formerly known as IntelliDot, raising…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?